Compounds > 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid
Page last updated: 2024-09-02

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and semustine

11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid has been researched along with semustine in 1 studies

Compound Research Comparison

Studies
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)		Trials
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)		Recent Studies (post-2010)
(11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid)		Studies
(semustine)		Trials
(semustine)		Recent Studies (post-2010) (semustine)
3042710349315224

Protein Interaction Comparison

ProteinTaxonomy11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid (IC50)semustine (IC50)
Alpha-2A adrenergic receptorHomo sapiens (human)4.809

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frytak, S; Moertel, CG; Rubin, J1

Other Studies

1 other study(ies) available for 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid and semustine

ArticleYear
Metabolic studies of delta-9-tetrahydrocannabinol in cancer patients.
    Cancer treatment reports, 1984, Volume: 68, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dronabinol; Female; Fluorouracil; Gastrointestinal Neoplasms; Half-Life; Humans; Kinetics; Liver Neoplasms; Male; Middle Aged; Semustine

1984